Skip to main content
Svas Biosana logo

Svas Biosana — Investor Relations & Filings

Ticker · SVS ISIN · IT0005469264 LEI · 81560055A88E1D16D537 XMIL Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2022-07-01 Transaction in Own Shar…
Country IT Italy
Listing XMIL SVS

About Svas Biosana

https://svas.it/en/

Svas Biosana is a company that specializes in the planning, manufacturing, and distribution of medical devices and pharmaceutical products. The company's portfolio includes a range of disposable hospital supplies, such as incontinence aids and traditional dressings. Serving both public and private health institutions, Svas Biosana develops, produces, and distributes its own branded products as well as those from third-party manufacturers.

Recent filings

Filing Released Lang Actions
Acquisto azioni proprie
Transaction in Own Shares Classification · 98% confidence The document is titled "INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE" (Weekly Information on Own Share Purchase) and details transactions made by the company (Svas Biosana S.p.A.) to buy back its own shares between June 27 and July 1, 2022. The key subject is the repurchase of shares, which directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this activity is POS. Although it is a regulatory communication (Informazione Regolamentata), the specific nature of the content points directly to POS rather than the general RNS fallback.
2022-07-01 Italian
Avvio primo 1° esercizio warrant Svas Biosana Spa
Share Issue/Capital Change Classification · 99% confidence The document is an official communication from Svas Biosana S.p.A. on Euronext Growth Milan, identified by the header 'Informazione Regolamentata' (Regulated Information). The subject ('Oggetto') is the 'Avvio primo 1° esercizio warrant Svas Biosana Spa' (Start of the first exercise period for Svas Biosana Warrants). The content details the opening of the first exercise period for specific warrants, including dates, exercise price (€14.375), and procedures for subscription. This announcement relates directly to the company's capital structure and financing instruments (warrants), specifically detailing an event related to capital changes or financing activities. This aligns best with the 'Capital/Financing Update' category (CAP). It is not a general earnings release (ER), a full annual report (10-K), or a general regulatory filing (RNS), as it concerns a specific corporate action related to capital instruments.
2022-06-28 Italian
Mid & Small Virtual 2022 - Giugno 2022
Investor Presentation Classification · 95% confidence The document is a regulatory announcement (Informazione Regolamentata) from SVAS BIOSANA S.p.A. dated June 28, 2022. The subject ('Oggetto') is 'Mid & Small Virtual 2022 - Giugno 2022'. The text explicitly states that the company will participate in the 'Mid & Small Conference, Virtual Edition 2022' on June 29th to meet institutional investors and will share an institutional presentation on the event day in the Investor Relations section of their website. Since the document itself is an announcement about participation in an investor event and the availability of a presentation, rather than the presentation itself or a formal financial report, it fits the description of an announcement regarding the publication or availability of investor materials. This aligns best with the Report Publication Announcement (RPA) category, as it announces the presentation will be made available, or alternatively, it could be a general Regulatory Filing (RNS). Given the context of announcing participation in a specific investor conference where presentations are shared, RPA is a strong fit, but RNS is the general regulatory fallback. Since the core action is announcing the availability of an investor presentation related to an event, and it is a short regulatory notice, I will classify it as RPA, as it is announcing the publication of investor materials, even if the material itself is not attached here. However, looking closely at the definitions, 'Investor Presentation' (IP) is for the presentation itself. This document is announcing participation and that the presentation *will be made available*. This makes it an announcement about investor relations activity, which often falls under RNS if not a specific report. Given the content is about attending an investor conference and updating the market, and it is a formal regulatory notice ('Informazione Regolamentata'), RNS (Regulatory Filings) is the most appropriate general category for this type of market update that isn't a formal financial report or a specific director dealing/dividend notice. The document length is 5399 characters, which is not extremely short, but it explicitly points to where the presentation will be found ('Vedi allegato' is followed by text stating the presentation 'sarà resa disponibile'). I will lean towards RNS as the most accurate general regulatory announcement type for this specific market update regarding conference participation.
2022-06-28 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is titled 'INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE' (Weekly Information on Own Share Purchase) and explicitly details the number of shares purchased, the average price, and the total consideration for the period June 20 to June 24, 2022. The subject line in the regulatory header is 'Acquisto azioni proprie' (Purchase of own shares). This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2022-06-24 Italian
Closing operazione acquisizione Bormia
M&A Activity Classification · 98% confidence The document is an official communication from SVAS BIOSANA S.p.A. dated June 23, 2022, identified as 'Informazione Regolamentata' (Regulated Information) on the Euronext Growth Milan market. The subject ('Oggetto') is 'Closing operazione acquisizione Bormia' (Closing of the Bormia acquisition operation). The text details the completion of the acquisition of 75% of Bormia d.o.o., including financial figures for the acquired entity and details of the transaction. This type of announcement, detailing a significant corporate transaction (M&A activity) released via regulatory channels, fits best under the 'M&A Activity' category (TAR). Although it is a regulatory filing, TAR is more specific than the general RNS fallback. It is not a full annual report (10-K), an earnings release (ER), or a quarterly report (IR).
2022-06-23 Italian
Acquisto azioni proprie
Transaction in Own Shares Classification · 99% confidence The document is an official communication ('Informazione Regolamentata') from Svas Biosana S.p.A. The subject ('Oggetto') is 'Acquisto azioni proprie' (Purchase of own shares). The body explicitly details the weekly activity of the company buying back its own shares ('INFORMATIVA SETTIMANALE ACQUISTO AZIONI PROPRIE') under an authorized program, providing daily transaction details and the resulting total holding of treasury shares. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase).
2022-06-17 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.